...
首页> 外文期刊>Biological psychiatry >Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
【24h】

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

机译:炎症及其不满:细胞因子在严重抑郁症病理生理中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recognition that inflammation may represent a common mechanism of disease has been extended to include neuropsychiatric disorders including major depression. Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomar-kers, including inflammatory cytokines, which have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter metabolism, neuroendocrine function, and neural plasticity. Indeed, activation of inflammatory pathways within the brain is believed to contribute to a confluence of decreased neurotrophic support and altered glutamate release/reuptake, as well as oxidative stress, leading to excitotoxicity and loss of glial elements, consistent with neuropathologic findings that characterize depressive disorders. Further instantiating the link between inflammation and depression are data demonstrating that psychosocial stress, a well-known precipitant of mood disorders, is capable of stimulating inflammatory signaling molecules, including nuclear factor kappa B, in part, through activation of sympathetic nervous system outflow pathways. Interestingly, depressed patients with increased inflammatory biomarkers have been found to be more likely to exhibit treatment resistance, and in several studies, antidepressant therapy has been associated with decreased inflammatory responses. Finally, preliminary data from patients with inflammatory disorders, as well as medically healthy depressed patients, suggest that inhibiting proinflammatory cytokines or their signaling pathways may improve depressed mood and increase treatment response to conventional antidepressant medication. Transla-tional implications of these findings include the unique opportunity to identify relevant patient populations, apply immune-targeted therapies, and monitor therapeutic efficacy at the level of the immune system in addition to behavior.
机译:对炎症可能代表疾病的常见机制的认识已经扩展到包括神经精神疾病,包括严重抑郁症。已发现患有重度抑郁症的患者表现出外周血炎性生物标记物增加,包括炎性细胞因子,这些物质已进入大脑并与已知与抑郁症有关的几乎所有病理生理学领域相互作用,包括神经递质代谢,神经内分泌功能,和神经可塑性。实际上,据信大脑内炎症途径的激活有助于神经营养支持的减少和谷氨酸释放/再摄取的改变以及氧化应激的汇合,从而导致兴奋性毒性和神经胶质元素的损失,这与表征抑郁症的神经病理学发现一致。进一步实例化炎症和抑郁之间的联系的数据表明,心理心理压力(一种众所周知的情绪障碍沉淀物)能够部分激活交感神经系统流出途径,从而刺激包括核因子κB在内的炎症信号分子。有趣的是,已发现炎症生物标志物增加的抑郁症患者更可能表现出治疗抵抗力,并且在一些研究中,抗抑郁治疗与炎症反应降低相关。最后,来自炎症性疾病患者以及医学上健康的抑郁症患者的初步数据表明,抑制促炎性细胞因子或其信号传导途径可以改善抑郁症的情绪并增加对常规抗抑郁药的治疗反应。这些发现的翻译意义包括独特的机会来识别相关的患者人群,应用免疫靶向疗法,以及在行为方面监测免疫系统水平的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号